Methotrexate-associated biochemical alterations in a patient with chronic neurotoxicity

• Main Authors: Vezmar Sandra, Bode Udo, Jaehde Ulrich
• Format: Article
• Language: English
• Published: Society of Medical Biochemists of Serbia, Belgrade 2009-01-01
• Series: Journal of Medical Biochemistry
• Subjects: methotrexate; csf; 5-methyltetrahydrofolate; s-adenosylmethionine; neurotoxicity
• Online Access: https://scindeks-clanci.ceon.rs/data/pdf/1452-8258/2009/1452-82580901011V.pdf
• ISSN: 1452-8258; 1452-8266

Intrathecal and/or high-dose intravenous administration of methotrexate (MTX) in the treatment of malignancies such as acute lymphoblastic leukaemia (ALL) has been associated with cases of mild to severe neurotoxicity. The pathogenic mechanism of neurotoxicity is not clear, possibly MTX-associated biochemical alterations of the folate and methyl-transfer metabolic pathways play an important role. We report a case of an adult patient treated for ALL relapse with signs of chronic leukoencephalopathy associated with MTX administration. In order to assess alterations in the folate and methyl-transfer pathway we determined 5-methyltetrahydrofolate (5-methyl-THF), S-adenosylmethionine (SAM) and S-adenosylhomocysteine (SAH) in the cerebrospinal fluid (CSF) of the patient. Three CSF samples were obtained by lumbar punction within a four-month period. Concentrations of the metabolites were measured using validated bioanalytical methods based on HPLC with UV and fluorescence detection. The results showed two-fold lower 5-methyl-THF levels (29.3-31.8 nmol/L) in all obtained samples compared to reference values. SAM concentrations were even more than five-fold lower in two samples (5-34.2 nmol/L). SAH concentrations were in the range 7.5-14.3 nmol/L. Our patient had pronounced alterations in the folate and methyltransfer pathway which indicate that MTX-associated biochemical alterations of these pathways may play an important role in the development of leukoencephalopathy.